Invention Grant
- Patent Title: Cannabinoid lozenge formulation
-
Application No.: US16852133Application Date: 2020-04-17
-
Publication No.: US11241413B2Publication Date: 2022-02-08
- Inventor: Heidi Ziegler Bruun , Dorthe Schackinger Boesen , Ane Eriksen
- Applicant: NordicCan A/S
- Applicant Address: DK Vejle
- Assignee: NordicCan A/S
- Current Assignee: NordicCan A/S
- Current Assignee Address: DK Vejle
- Agency: St. Onge Steward Johnston & Reens LLC
- Priority: CACA3040547 20190417
- Main IPC: A61K31/352
- IPC: A61K31/352 ; A61K9/00 ; A61K31/05 ; A61K47/02 ; A61K47/26 ; A61K47/40 ; A61K47/38
Abstract:
The present invention relates to a lozenge composition for controlled release of cannabinoids comprising; i) a master granule component comprising one or more solid particles and one or more cannabinoids reversibly associated with the one or more solid particles; and ii) an extragranular component blended with the master granule component comprising one or more extragranular sugar alcohols.
Public/Granted literature
- US20200330424A1 CANNABINOID LOZENGE FORMULATION Public/Granted day:2020-10-22
Information query
